TY - JOUR
T1 - Late-Life Depressive Symptoms as Partial Mediators in the Associations between Subclinical Cardiovascular Disease with Onset of Mild Cognitive Impairment and Dementia
AU - Armstrong, Nicole M.
AU - Carlson, Michelle C.
AU - Schrack, Jennifer
AU - Xue, Qian Li
AU - Carnethon, Mercedes R.
AU - Rosano, Caterina
AU - Chaves, Paulo H.M.
AU - Gross, Alden L.
N1 - Funding Information:
NMA was supported by fellowship from the Epidemiology and Biostatistics of Aging Training grant ( 5T32AG000247 ). This research was supported by contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and grants U01HL080295 and U01HL130114 from the National Heart, Lung, and Blood Institute ; with additional contribution from the National Institute of Neurological Disorders and Stroke . Additional support was provided by R01AG023629 from the National Institute on Aging . A full list of principal CHS investigators and institutions can be found at https://chs-nhlbi.org .
Publisher Copyright:
© 2017 American Association for Geriatric Psychiatry
PY - 2018/5
Y1 - 2018/5
N2 - Objective: To study whether depression contributes to the association between subclinical cardiovascular disease (CVD) and dementia, and identify the contribution's magnitude. Methods: Among participants from the Cardiovascular Health Study Cognition Study who did not have baseline CVD-related events (N = 2,450), causal mediation methodology was implemented to examine whether late-life depressive symptoms, defined as 10-item Center for Epidemiologic Studies-Depression (mCES-D) Scale scores ≥8 from 2 to 3 years after baseline, partially mediated the association of baseline subclinical CVD (CAC, carotid intimal medial thickness, stenosis, and ankle brachial index) with mild cognitive impairment (MCI)/dementia onset occurring between 5 and 10 years from baseline. The total effect was decomposed into direct and indirect effects (via late-life depressive symptoms), obtained from an accelerated failure time model with weights derived from multivariable logistic regression of late-life depressive symptoms on subclinical CVD. Analyses were adjusted by baseline covariates: age, race, sex, poverty status, marital status, body mass index, smoking status, ApoE4 status, and mCES-D. Results: Participants contributed 20,994 person-years of follow-up with a median follow-up time of 9.4 years. Subclinical CVD was associated with 12% faster time to MCI/dementia (time ratio [TR]: 0.88; 95% CI: 0.83, 0.93). The total effect of subclinical CVD on MCI/dementia onset was decomposed into a direct effect (TR: 0.95, 95% CI: 0.92, 0.98) and indirect effect (TR: 0.92, 95% CI: 0.88, 0.97); 64.5% of the total effect was mediated by late-life depressive symptoms. Conclusions: These data suggest late-life depressive symptoms partially mediate the association of subclinical CVD with MCI/dementia onset.
AB - Objective: To study whether depression contributes to the association between subclinical cardiovascular disease (CVD) and dementia, and identify the contribution's magnitude. Methods: Among participants from the Cardiovascular Health Study Cognition Study who did not have baseline CVD-related events (N = 2,450), causal mediation methodology was implemented to examine whether late-life depressive symptoms, defined as 10-item Center for Epidemiologic Studies-Depression (mCES-D) Scale scores ≥8 from 2 to 3 years after baseline, partially mediated the association of baseline subclinical CVD (CAC, carotid intimal medial thickness, stenosis, and ankle brachial index) with mild cognitive impairment (MCI)/dementia onset occurring between 5 and 10 years from baseline. The total effect was decomposed into direct and indirect effects (via late-life depressive symptoms), obtained from an accelerated failure time model with weights derived from multivariable logistic regression of late-life depressive symptoms on subclinical CVD. Analyses were adjusted by baseline covariates: age, race, sex, poverty status, marital status, body mass index, smoking status, ApoE4 status, and mCES-D. Results: Participants contributed 20,994 person-years of follow-up with a median follow-up time of 9.4 years. Subclinical CVD was associated with 12% faster time to MCI/dementia (time ratio [TR]: 0.88; 95% CI: 0.83, 0.93). The total effect of subclinical CVD on MCI/dementia onset was decomposed into a direct effect (TR: 0.95, 95% CI: 0.92, 0.98) and indirect effect (TR: 0.92, 95% CI: 0.88, 0.97); 64.5% of the total effect was mediated by late-life depressive symptoms. Conclusions: These data suggest late-life depressive symptoms partially mediate the association of subclinical CVD with MCI/dementia onset.
KW - Depressive symptoms
KW - dementia
KW - mild cognitive impairment
KW - subclinical cardiovascular disease
UR - http://www.scopus.com/inward/record.url?scp=85039421526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039421526&partnerID=8YFLogxK
U2 - 10.1016/j.jagp.2017.11.004
DO - 10.1016/j.jagp.2017.11.004
M3 - Article
C2 - 29254675
AN - SCOPUS:85039421526
SN - 1064-7481
VL - 26
SP - 559
EP - 568
JO - American Journal of Geriatric Psychiatry
JF - American Journal of Geriatric Psychiatry
IS - 5
ER -